08.06.2021
Pipeline Review: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine”
Precision Vaccinations: “Protein Subunit COVID-19 Vaccine Candidate Seeks Phase 2 Participants”
Pharmaceutical Business Review: “Akston commences dosing in Phase II trial of Covid-19 vaccine”
Angel Invest Boston:”Todd Zion, PhD, CEO and Repeat Founder, ‘Magical Proteins'”
08.05.2021
BioSpace: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine”
Pharmaceutical Daily: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine”
First Word Pharma: ‘Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine”
Akston Biosciences: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine”
08.01.2021
Milford Daily News: “Movers & Shakers: Jennifer Derkazarian joins Hebrew SeniorLife”
07.29.2021
Jewish Journal: “From Camp Alton to NewBridge on the Charles: 70 years of friendship”
Contract Pharma: “Akston Biosciences, Seppic Ink Commercial Supply Agreement: Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale”
07.28.2021
McKnight’s Senior Living: “Business Briefs, July 28: Hebrew SeniorLife to require current employees to receive COVID-19 vaccine by Oct. 1, new hires by start date”
